BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17658235)

  • 1. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
    Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
    Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI.
    Gibbs P; Liney GP; Lowry M; Kneeshaw PJ; Turnbull LW
    Breast; 2004 Apr; 13(2):115-21. PubMed ID: 15019691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural network approach to the segmentation and classification of dynamic magnetic resonance images of the breast: comparison with empiric and quantitative kinetic parameters.
    Szabó BK; Aspelin P; Wiberg MK
    Acad Radiol; 2004 Dec; 11(12):1344-54. PubMed ID: 15596372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Jaeger H; Maderwald S; Stockamp C; Mühler A; Kimmig R; Forsting M
    Eur Radiol; 2006 Dec; 16(12):2834-41. PubMed ID: 16896702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
    Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
    J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
    Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
    Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved lesion detection in MR mammography: three-dimensional segmentation, moving voxel sampling, and normalized maximum intensity-time ratio entropy.
    Ertaş G; Gülçür HO; Tunaci M
    Acad Radiol; 2007 Feb; 14(2):151-61. PubMed ID: 17236988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering.
    Chang YC; Huang YH; Huang CS; Chang PK; Chen JH; Chang RF
    Magn Reson Imaging; 2012 Apr; 30(3):312-22. PubMed ID: 22245697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative parametric analysis of contrast-enhanced lesions in dynamic MR mammography].
    Hauth EA; Jaeger H; Maderwald S; Mühler A; Kimmig R; Forsting M
    Radiologe; 2008 Jun; 48(6):593-600. PubMed ID: 18004537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
    Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical MR-mammography: are computer-assisted methods superior to visual or manual measurements for curve type analysis? A systematic approach.
    Baltzer PA; Freiberg C; Beger S; Vag T; Dietzel M; Herzog AB; Gajda M; Camara O; Kaiser WA
    Acad Radiol; 2009 Sep; 16(9):1070-6. PubMed ID: 19523854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of probably benign lesions (BI-RADS 3 category) in breast MR imaging.
    Hauth E; Umutlu L; Kümmel S; Kimmig R; Forsting M
    Breast J; 2010; 16(3):297-304. PubMed ID: 20565469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.
    Vincensini D; Dedieu V; Eliat PA; Vincent C; Bailly C; de Certaines J; Joffre F
    Magn Reson Imaging; 2007 Apr; 25(3):293-302. PubMed ID: 17371717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging.
    Kneeshaw PJ; Lowry M; Manton D; Hubbard A; Drew PJ; Turnbull LW
    Breast; 2006 Feb; 15(1):29-38. PubMed ID: 16002292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
    Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR factor analysis: improved technology for the assessment of 2D dynamic structures of benign and malignant salivary gland tumors.
    Eida S; Ohki M; Sumi M; Yamada T; Nakamura T
    J Magn Reson Imaging; 2008 Jun; 27(6):1256-62. PubMed ID: 18504743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.